| Long name: |
Recombinant Mesocricetus auratus Caspase-3 (CASP3) |
| Alternative names: |
Apopain, CPP-32, Caspase-3, Cysteine protease CPP32, Cysteine protease CPP32, Protein Yama, Protein Yama, SCA-1, SREBP cleavage activity 1, SREBP cleavage activity 1, caspase-3, caspase-3 |
| Gene name: |
CASP3 |
| Other gene names: |
Apopain, CASP-3, CASP-3, CASP3, CPP-32, CPP-32, CPP32, CPP32, Caspase-3, SCA-1, SCA-1, Casp3 |
| General description: |
All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, coli, Caspase-3(CASP3) is a recombinant protein expressed in E |
| Product category: |
Recombinant Proteins |
| Expression system: |
coli, E |
| Available also expressed in:: |
Baculovirus , Mammalian Cell, Yeast , E Coli |
| Purity: |
Greater than 90% (determined by SDS-PAGE) |
| Form: |
Lyophilized protein |
| Storage: |
Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius |
| Applications: |
IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA |
| Gene target: |
Mesocricetus auratus Caspase-3 (CASP3) |
| Short name: |
Mesocricetus auratus Caspase-3 (CASP3) |
| Alternative name: |
apoptosis-related cysteine peptidase), Mesocricetus auratus caspase-3 (caspase 3 |
| Alternative to gene target: |
CASP3 and IDBG-46394 and ENSG00000164305 and 836, CASP3 and IDBG-628521 and ENSBTAG00000015874 and 408016, CPP32 and CPP32B and SCA-1, Casp3 and IDBG-154306 and ENSMUSG00000031628 and 12367, apoptosis-related cysteine peptidase, cysteine-type endopeptidase activity involved in execution phase of apoptosis, nuclei, this GO :0001782 and B cell homeostasis and biological process this GO :0001836 and release of cytochrome c from mitochondria and biological process this GO :0004190 and aspartic-type endopeptidase activity and molecular function this GO :0004197 and cysteine-type endopeptidase activity and molecular function this GO :0004861 and cyclin-dependent protein serine/threonine kinase inhibitor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005654 and nucleoplasm and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006309 and apoptotic DNA fragmentation and biological process this GO :0006508 and proteolysis and biological process this GO :0006915 and apoptotic process and biological process this GO :0006921 and cellular component disassembly involved in execution phase of apoptosis and biological process this GO :0006974 and cellular response to DNA damage stimulus and biological process this GO :0007507 and heart development and biological process this GO :0007605 and sensory perception of sound and biological process this GO :0008233 and peptidase activity and molecular function this GO :0008234 and cysteine-type peptidase activity and molecular function this GO :0008625 and extrinsic apoptotic signaling pathway via death domain receptors and biological process this GO :0008631 and intrinsic apoptotic signaling pathway in response to oxidative stress and biological process this GO :0008635 and activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c and biological process this GO :0009411 and response to UV and biological process this GO :0009611 and response to wounding and biological process this GO :0016485 and protein processing and biological process this GO :0022617 and extracellular matrix disassembly and biological process this GO :0030182 and neuron differentiation and biological process this GO :0030198 and extracellular matrix organization and biological process this GO :0030216 and keratinocyte differentiation and biological process this GO :0030218 and erythrocyte differentiation and biological process this GO :0030220 and platelet formation and biological process this GO :0030889 and negative regulation of B cell proliferation and biological process this GO :0034349 and glial cell apoptotic process and biological process this GO :0034612 and response to tumor necrosis factor and biological process this GO :0035329 and hippo signaling and biological process this GO :0042981 and regulation of apoptotic process and biological process this GO :0043029 and T cell homeostasis and biological process this GO :0043065 and positive regulation of apoptotic process and biological process this GO :0043066 and negative regulation of apoptotic process and biological process this GO :0043281 and regulation of cysteine-type endopeptidase activity involved in apoptotic process and biological process this GO :0043525 and positive regulation of neuron apoptotic process and biological process this GO :0045165 and cell fate commitment and biological process this GO :0045736 and negative regulation of cyclin-dependent protein serine/threonine kinase activity and biological process this GO :0045786 and negative regulation of cell cycle and biological process this GO :0046007 and negative regulation of activated T cell proliferation and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0051402 and neuron apoptotic process and biological process this GO :0071310 and cellular response to organic substance and biological process this GO :0097153 and cysteine-type endopeptidase activity involved in apoptotic process and molecular function this GO :0097190 and apoptotic signaling pathway and biological process this GO :0097192 and extrinsic apoptotic signaling pathway in absence of ligand and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :0097194 and execution phase of apoptosis and biological process this GO :0097200 and cysteine-type endopeptidase activity involved in execution phase of apoptosis and molecular function this GO :1902510 and regulation of apoptotic DNA fragmentation and biological process, this GO :0004190 : aspartic-type endopeptidase activity, this GO :0004190 : aspartic-type endopeptidase activity and also this GO :0004197 : cysteine-type endopeptidase activity and also this GO :0004861 : cyclin-dependent protein serine/threonine kinase inhibitor activity and also this GO :0005515 : protein binding and also this GO :0008233 : peptidase activity and also this GO :0008234 : cysteine-type peptidase activity and also this GO :0097153 : cysteine-type endopeptidase activity involved in apoptotic process and also this GO :0097200 : cysteine-type endopeptidase activity involved in execution phase of apoptosis, this GO :0004197 : cysteine-type endopeptidase activity, this GO :0004861 : cyclin-dependent protein serine/threonine kinase inhibitor activity, this GO :0005515 : protein binding, this GO :0008233 : peptidase activity, this GO :0008234 : cysteine-type peptidase activity, this GO :0097153 : cysteine-type endopeptidase activity involved in apoptotic process, this GO :0097200 : cysteine-type endopeptidase activity involved in execution phase of apoptosis, caspase 3 |
| Identity: |
1504 |
| Gene: |
CASP3 |
More about : CASP3 |
| Long gene name: |
caspase 3 |
| Synonyms gene name: |
apoptosis-related cysteine peptidase , apoptosis-related cysteine protease caspase 3, caspase 3 |
| Synonyms: |
CPP32 CPP32B Yama apopain |
| Locus: |
4q35, 1 |
| Discovery year: |
1996-07-22 |
| GenBank acession: |
BC016926 |
| Entrez gene record: |
836 |
| Pubmed identfication: |
8780721 |
| RefSeq identity: |
NM_004346 |
| Classification: |
Caspases |
| Havana BLAST/BLAT: |
OTTHUMG00000133681 |